Cardiothoracic Surgery
MD, PhD, Director, Professor, Chief physician, Liaoning Cancer Hospital Institute, China
Professor of China Medical University, Deputy Director of Liaoning Cancer Hospital/Cancer Hospital of China Medical University, Chief of Department of Thoracic Surgery, Director of Liaoning Esophageal Cancer Key Laboratory, Shenyang, Liaoning, China. A member of IASLC, ESTS and committee members of a series of Chinese thoracic surgeons, chest physicians and oncology societies. Chair of Lung Cancer subcommittee in Liaoning Anti-Cancer Society, Chair-Elect of Liaoning Thoracic Surgeon Society. Chinese Society of Clinical Oncology（CSCO）Experts in establishing guidelines for diagnosis and treatment of primary lung cancer. National speaker of Johnson-Johnson and Medtronic companies. Deputy General Secretary of Professor Li Hou-Wen Medical Education and Development Foundation. Got his Bachelor degree in Medicine in 1995, Master degree in thoracic surgery in 1997 and PhD from China Medical University in 2003. In the period from 2006-2007, he received surgical trainings in some prestigious American hospitals, including Memorial Sloan-Kettering Cancer Center, Massachusetts General Hospital, Mayo Clinic and California University Los-Angeles. He received BiMBA business courses of advanced hospital administration in National Development Institute of Peiking University from Oct. 2016 to June 2017. Won quite a few awards, including Developing Nation Travel Award in 10th WCLC in 2003, Vancouver, Canada. First Liaoning Famous Youth Doctor. Won several prizes for VATS performance, including the Championship in Video VATS competition of Chinese Clinical Oncology Conference in 2018, He conducted scientific research in Karolinska Institute, Sweden in 2000-2001. As a thoracic surgeon, he actively diagnoses and treats numerous patients with lung cancer, esophageal cancer, ediastinal tumors and chest wall deformities, completing 30-40 cases of surgeries per month, and about 400 cases per year. Special interests in difficult cases, severe adhesion, redo surgery, and neoadjuvant therapy. Known for sleeve resection, double-sleeve resection, extended resection, reconstruction of major vessels, reconstruction of chest wall, comprehensive and multimodality treatment. Also good at VATS, minimally invasive surgery, especially singeport lobectomy, segmentectomy, and even sleeve lobectomy, and modified Nuss procedure for pectus excavatum and pectus carinatum, transthoracic and subxiphoid procedure for pulmonary and mediastinal tumors. He performed a lot of first cases of operations in his hospital and in the area where he served. He has a total of 52 publications as first author or correspondent, half of them in English SCI journals, including in the journals of Cancer Research, Lung Cancer, et al. Took part in the translations of two books from English into Chinese and editing five textbooks in Chinese. Got a total of 13 financial support of national and provincial projects and grants. Held meetings of the First and Second Liaoning International Symposium on Lung Cancer. A number of live performance through web broadcast for single-port VATS and non-intubated general anesthesia. Many oral presentations in domestic and international meetings.
Selected publications from PubMed
The surgical approach strategies in the treatment of anterior mediastinal tumors.
Xie J, Wang H, Han T, Tong W, Guo X, Zhang M, Liu D, Liu H, Zhang L
Ann Med. 2026 Dec;58(1):2609354 doi: 10.1080/07853890.2025.2609354.
Growth Patterns and Risk Stratification of Incidental Small Pure Ground-Glass Nodules across Independent Cohorts.
Liu H, Fu X, Ye M, Wang Z, Hu B, Wu S, Sun C, Sheng P, Chen Z, Sun H, Cho WC, Witharana P, Ma D, Shen J
Radiology. 2026 Aug;320(2):e253139 doi: 10.1148/radiol.253139.
USP30 senses serine/glycine levels to regulate serine biosynthesis and colorectal tumorigenesis by deubiquitinating FTO.
Qiao Y, Wang C, Liu H, Sun H, Zhao H, Zhang Q, Dai X, Sun M, Wang T, He T, Li Z, Li Y, Xue J, Zhang C, Shan C, Zhang S
Cell Death Differ. 2026 Aug;33(8):1617-1633 doi: 10.1038/s41418-026-01680-2.
LTB4R inhibits apoptosis and induces radiosensitivity by promoting the PI3K/AKT pathway in esophageal squamous cell carcinoma.
Li Y, Ma D, Liang J, Yu J, Zhou H, Liu H, Zhang Y, Sheng P, Ye M, Wang C, Kong M, Chen X, Shen J
J Thorac Dis. 2026 Jul 31;18(7):745 doi: 10.21037/jtd-2026-0819.
Antithrombotic treatment for migraine in patients with patent foramen ovale: multicentre, randomised, active controlled, open label trial.
Li Z, Wang C, Tang Y, Dong J, Dong J, Ouyang W, Zhang F, Pan J, Wan J, Han Y, Yang K, Liu Y, Wang Q, Li B, Tursun I, Shen Q, Li S, Lai H, Che H, Wang G, Ma Q, Hang Y, Huang K, Li Y, Wang P, Gao F, Liu W, Zhang H, Hu H, You T, Liu H, Chen L, Cheng Y, Zhang C, Wang R, Chen Z, Gong M, Fu Q, He C, Wang P, Shen C, Tan H, Zhang X, Zhang X, Zhang R, Wang Y, Pan X
BMJ. 2026 Jul 29;394:e100103 doi: 10.1136/bmj-2026-100103.
Help your network discover Dr. Hongxu Liu's clinical expertise.
